Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study – the importance of comprehensive clinical evaluation

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 2.46 MB, PDF document

  • B. Ratajczak-Tretel
  • A. Tancin Lambert
  • R. Al-Ani
  • K. Arntzen
  • G. K. Bakkejord
  • H. M.O. Bekkeseth
  • V. Bjerkeli
  • G. Eldøen
  • A. K. Gulsvik
  • B. Halvorsen
  • G. A. Høie
  • H. Ihle-Hansen
  • S. Ingebrigtsen
  • C. Kremer
  • S. B. Krogseth
  • M. Kurz
  • I. Nakstad
  • V. Novotny
  • H. Naess
  • R. Qazi
  • M. K. Rezaj
  • D. M. Rørholt
  • L. H. Steffensen
  • J. Sømark
  • H. Tobro
  • L. Wassvik
  • K. L. Ægidius
  • D. Atar
  • A. H. Aamodt

Background: Cryptogenic stroke is a heterogeneous condition, with a wide spectrum of possible underlying causes for which the optimal secondary prevention may differ substantially. Attempting a correct etiological diagnosis to reduce the stroke recurrence should be the fundamental goal of modern stroke management. Methods: Prospective observational international multicenter study of cryptogenic stroke and cryptogenic transient ischemic attack (TIA) patients clinically monitored for 12 months to assign the underlying etiology. For atrial fibrillation (AF) detection continuous cardiac rhythm monitoring with insertable cardiac monitor (Reveal LINQ, Medtronic) was performed. The 12-month follow-up data for 250 of 259 initially included NOR-FIB patients were available for analysis. Results: After 12 months follow-up probable stroke causes were revealed in 43% patients, while 57% still remained cryptogenic. AF and atrial flutter was most prevalent (29%). In 14% patients other possible causes were revealed (small vessel disease, large-artery atherosclerosis, hypercoagulable states, other cardioembolism). Patients remaining cryptogenic were younger (p < 0.001), had lower CHA2DS2-VASc score (p < 0.001) on admission, and lower NIHSS score (p = 0.031) and mRS (p = 0.016) at discharge. Smoking was more prevalent in patients that were still cryptogenic (p = 0.014), while dyslipidaemia was less prevalent (p = 0.044). Stroke recurrence rate was higher in the cryptogenic group compared to the group where the etiology was revealed, 7.7% vs. 2.8%, (p = 0.091). Conclusion: Cryptogenic stroke often indicates the inability to identify the cause in the acute phase and should be considered as a working diagnosis until efforts of diagnostic work up succeed in identifying a specific underlying etiology. Timeframe of 6-12-month follow-up may be considered as optimal. Trial registration: ClinicalTrials.gov Identifier NCT02937077, EudraCT 2018-002298-23.

Original languageEnglish
Article number115
JournalBMC Neurology
Volume23
Issue number1
Number of pages10
ISSN1471-2377
DOIs
Publication statusPublished - 2023

Bibliographical note

Funding Information:
Open access funding provided by University of Oslo (incl Oslo University Hospital). NOR-FIB is an investigator driven academic study, supported by Oslo University Hospital, Norwegian Health Association, South-Eastern Norway Regional Health Authority, Østfold Hospital Trust and the European Cerebrovascular Research Infrastructure (ECRI). Devices were partly provided by Medtronic. BRT and ATL are funded by a PhD fellowship from South-Eastern Norway Regional Health Authority.

Publisher Copyright:
© 2023, The Author(s).

    Research areas

  • Atrial fibrillation, Cryptogenic stroke, Guidelines, Insertable cardiac monitor, Secondary prevention, Stroke cause

ID: 372805440